Predictors for PARP inhibitor hematologic toxicity in ovarian cancer: Are patients with chemotherapy-induced toxicity at an increased risk?

被引：0
|
作者：
Salman, Lina [1 ]
Fowler, Ryley [2 ]
Maganti, Manjula [1 ]
Bernardini, Marcus [1 ]
Bouchard-Fortier, Genevieve [1 ]
Hogen, Liat [1 ]
Kim, Rachel Soyoun [1 ]
Laframboise, Stephane [1 ]
May, Taymaa [1 ]
Philp, Lauren [1 ]
Ferguson, Sarah [1 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Univ Edinburgh, Toronto, ON, Canada
来源：
GYNECOLOGIC ONCOLOGY | 2024年 / 190卷
关键词：
D O I：
10.1016/j.ygyno.2024.07.593
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2303
引用
收藏
页码：S400 / S401
页数：2
相关论文
共 50 条
  • [1] Effect of age on chemotherapy-induced hematologic toxicity
    Ganti, A. K.
    Loberiza, F. R., Jr.
    Kessinger, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Exploring the effect of BRCA1/2 status on chemotherapy-induced hematologic toxicity in patients with ovarian cancer
    Lee, In Hee
    Lee, Soo Jung
    Kim, Juhyung
    Lee, Yoon Hee
    Chong, Gun Oh
    Kim, Jong Mi
    Lee, Juhun
    Lee, Nan Young
    Park, Seo Young
    Hong, Dea Gy
    Chae, Yee Soo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 94 (01) : 103 - 108
  • [3] Chemotherapy-Induced Pulmonary Toxicity in Lung Cancer Patients
    Ryu, Jay H.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (09) : 1313 - 1314
  • [4] ABSENCE OF AGE-DEPENDENT CHEMOTHERAPY-INDUCED HEMATOLOGIC TOXICITY
    HRUSHESKY, W
    KENNEDY, BJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 137 - 137
  • [5] Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity
    Cho, Hyun-Woong
    Lee, Sanghoon
    Min, Kyung-Jin
    Hong, Jin Hwa
    Song, Jae Yun
    Lee, Jae Kwan
    Lee, Nak Woo
    Kim, Tak
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (20) : 1 - 20
  • [6] What lies behind chemotherapy-induced ovarian toxicity?
    Ben-Aharon, Irit
    Shalgi, Ruth
    REPRODUCTION, 2012, 144 (02) : 153 - 163
  • [7] Clinical and preclinical modulation of chemotherapy-induced toxicity in patients with cancer
    Hoekman, K
    van der Vijgh, WJF
    Vermorken, JB
    DRUGS, 1999, 57 (02) : 133 - 155
  • [8] Clinical and Preclinical Modulation of Chemotherapy-Induced Toxicity in Patients with Cancer
    Klaas Hoekman
    Wim J. F. van der Vijgh
    Jan B. Vermorken
    Drugs, 1999, 57 : 133 - 155
  • [9] Out-of-pocket costs for PARP inhibitor treatment: Are ovarian cancer patients at risk for financial toxicity?
    Harrison, R. F.
    Fu, S.
    Sun, C. C.
    Zhao, H.
    Lu, K. H.
    Giordano, S. H.
    Meyer, L.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 21 - 21
  • [10] Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer
    Torino, Francesco
    Barnabei, Agnese
    De Vecchis, Liana
    Sini, Valentina
    Schittulli, Francesco
    Marchetti, Paolo
    Corsello, Salvatore Maria
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 89 (01) : 27 - 42
12345